InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Novion Property Group
Forum | Tag | Subject | View | Poster | |||||
---|---|---|---|---|---|---|---|---|---|
ASX - By Stock | NVN | Ann: CFX becomes Novion Property Group | Thread | ASX News | 0 | 390 | 0 | 03/11/14 | |
|